Skip to main content
. 2020 Jun 1;20:500. doi: 10.1186/s12885-020-06987-y

Fig. 5.

Fig. 5

Five-year survival of patients expressing high CD45RO/ICOS vs low CD45RO/ICOS in the validation cohort. Cases falling into the high group are represented by the red line with the blue line representing low expression